CRIS Current Research Information System

SABATTINI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.665
AS - Asia 5.822
NA - Nord America 5.793
SA - Sud America 469
AF - Africa 394
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.171
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.671
IT - Italia 5.042
SG - Singapore 1.851
CN - Cina 1.787
VN - Vietnam 922
GB - Regno Unito 863
DE - Germania 550
SE - Svezia 544
HK - Hong Kong 473
BR - Brasile 334
FR - Francia 283
IN - India 270
NL - Olanda 267
RU - Federazione Russa 231
KR - Corea 203
IE - Irlanda 163
UA - Ucraina 126
JP - Giappone 111
CH - Svizzera 96
SC - Seychelles 96
ZA - Sudafrica 95
FI - Finlandia 88
TG - Togo 88
CI - Costa d'Avorio 86
BG - Bulgaria 78
MX - Messico 64
AR - Argentina 57
CA - Canada 49
EE - Estonia 49
ID - Indonesia 48
AT - Austria 43
ES - Italia 42
BE - Belgio 35
JO - Giordania 35
GR - Grecia 30
PL - Polonia 27
PT - Portogallo 27
TW - Taiwan 23
CL - Cile 20
EC - Ecuador 20
RO - Romania 20
TR - Turchia 17
AU - Australia 16
BD - Bangladesh 15
CO - Colombia 13
HR - Croazia 13
LT - Lituania 12
PK - Pakistan 12
NZ - Nuova Zelanda 11
PE - Perù 10
SI - Slovenia 10
HU - Ungheria 8
MA - Marocco 7
MY - Malesia 7
NG - Nigeria 7
IQ - Iraq 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
NO - Norvegia 5
UZ - Uzbekistan 5
VE - Venezuela 5
DK - Danimarca 4
KZ - Kazakistan 4
AM - Armenia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
IL - Israele 3
SM - San Marino 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
GT - Guatemala 2
JM - Giamaica 2
MZ - Mozambico 2
NP - Nepal 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
NA - Namibia 1
OM - Oman 1
RE - Reunion 1
Totale 21.167
Salva come PNG Salva come JPEG
Città #
Singapore 1.203
Southend 680
Ashburn 661
Milan 501
Chandler 476
Hong Kong 470
Fairfield 438
Hefei 422
Dong Ket 347
Santa Clara 338
Rome 324
Bologna 287
Ann Arbor 286
Beijing 223
Woodbridge 212
Wilmington 206
Seattle 205
Princeton 204
Seoul 192
Houston 183
Ho Chi Minh City 173
Dublin 160
Cambridge 155
Dallas 145
Boardman 143
Hanoi 129
Turin 129
Florence 114
Los Angeles 101
Lomé 88
Abidjan 86
Westminster 79
Nanjing 78
New York 77
Sofia 75
Naples 73
Padova 73
Tokyo 72
Berlin 65
Frankfurt am Main 65
Genoa 61
Brescia 57
Helsinki 53
Redondo Beach 52
Buffalo 50
Jinan 50
Jacksonville 49
Palermo 48
Shenyang 45
Medford 43
Redmond 42
São Paulo 42
Redwood City 40
Guangzhou 38
Bengaluru 37
San Diego 37
Bari 36
Dearborn 36
Amman 35
Saint Petersburg 33
Brussels 32
Munich 32
Zurich 32
Jakarta 31
Ancona 30
Changsha 30
Hebei 29
Nuremberg 29
Parma 29
Verona 29
Des Moines 27
Hyderabad 27
London 27
Monza 26
Shanghai 26
Phoenix 25
Cesena 24
Jiaxing 23
Messina 23
Nanchang 23
Tianjin 23
Modena 21
Moscow 21
Paris 21
Amsterdam 20
Haiphong 20
Lappeenranta 20
Mülheim 20
Bergamo 19
Brooklyn 19
Catania 19
Toronto 19
Vienna 19
Cagliari 18
Falls Church 18
Livorno 18
Napoli 18
Orem 18
Council Bluffs 17
Düsseldorf 17
Totale 11.761
Salva come PNG Salva come JPEG
Nome #
Attività antitumorale di un nuovo farmaco in due casi di linfoma cutaneo felino non responsivi a lomustina 1.314
Indicatori istopatologici di prognosi nel mastocitoma cutaneo e viscerale del gatto 1.114
Aspetto citologico, grado istologico, margini chirurgici e immunoistochimica del mastocitoma canino: in aiuto al clinico 1.000
Grading citologico del mastocitoma cutaneo del cane 712
Istologia, immunoistochimica e c-Kit nel mastocitoma felino: quanto servono al clinico? 602
Emangiosarcoma: aspetti istopatologici e marker diagnostici 286
Comparison between May-Grünwald-Giemsa and rapid cytological stains in fine-needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications 272
The 2-tier grading system identifies canine cutaneous and/or subcutaneous mast cell tumors with aggressive biological behavior regardless of growth model 269
Feline large granular lymphocyte lymphoma: An Italian Society of Veterinary Oncology (SIONCOV) retrospective study 242
Canine Splenic Nodular Lymphoid Lesions: Immunophenotyping, Proliferative Activity, and Clonality Assessment 228
Intraoperative methylene blue staining is effective as a single mapping technique in the identification of sentinel lymph nodes in dogs with low‐grade mast cell tumours 210
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumor: diagnostic and prognostic implications 210
Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa 201
Mastociti in circolo: semplici spettatori o partecipanti attivi? Controversie, diagnosi e prognosi della mastocitosi/mastocitemia felina 191
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery 191
Cytological differentiation between benign and malignant perianal gland proliferative lesions in dogs: a preliminary study 190
Comparative Assessment of the Accuracy of Cytological and Histologic Biopsies in the Diagnosis of Canine Bone Lesions 189
Environmental risk factors for the development of oral squamous cell carcinoma in cats 184
Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis 181
Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision 179
Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non-neoplastic mucosa: A preliminary study 177
Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014) 176
A retrospective Italian Society of Veterinary Oncology (SIONCOV) study of 56 cats with appendicular osteosarcoma 175
An Evolutionary Cancer Epigenetic Approach Revealed DNA Hypermethylation of Ultra-Conserved Non-Coding Elements in Squamous Cell Carcinoma of Different Mammalian Species 175
Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers 174
Assessment of PDGFRβ promoter methylation in canine osteosarcoma using methylation-sensitive high-resolution melting analysis 174
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumours: diagnostic and prognostic implications. 171
Comparison of definitive-intent finely fractionated and palliative-intent coarsely fractionated radiotherapy as adjuvant treatment of feline microscopic injection-site sarcoma 167
EGFR expression is predictive of a poor prognosis in feline cutaneous squamous cell carcinoma. 167
Papillomavirus associated malignancies in dogs and cats 165
Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma 162
Adjuvant dose-intense versus metronomic chemotherapy for dogs with metastatic splenic hemangiosarcoma: a multi-institutional retrospective study. 161
Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma 161
Ultrasonographic honeycomb pattern of the spleen in cats: correlation with pathological diagnosis in 33 cases 161
A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors 160
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy 159
Reclassification of 21 presumptive canine peripheral nerve sheath tumors (pnst) using a literature-based immunohistochemical panel 154
Enhanced therapeutic effect of APAVAC vaccine in combination with dose-intense chemotherapy in dogs with clinically-advanced multicentric indolent B-cell lymphoma. 154
P16 immunostaining of canine squamous cell carcinomas is not associated with papillomaviral DNA 153
A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma 150
Longitudinal lymph node step-sectioning for the identification of metastatic disease in canine mast cell tumor 146
Treatment of oral squamous cell carcinoma in a horse by surgical debulking followed by metronomic chemotherapy 146
Metastatic Adenocarcinoma of Unknown Primary Origin Presenting with Severe Lumbar Neuropathic Pain in a Dog 146
Prognostic value of peripheral blood and bone marrow infiltration assessed by flow cytometry in dogs with de novo nodal peripheral T-cell lymphoma receiving alkylating-rich chemotherapy 145
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain 144
Periarticular histiocytic sarcoma with heart metastasis in a cat 143
Evaluation of Ki-67 expression in feline non-ocular melanocytic tumours 142
Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology study 142
Prognostic Value of Histologic and Immunohistochemical Features in Feline Cutaneous Mast Cell Tumors 140
Esperienze cliniche ed anatomopatologiche sulla c.d. Pancitopenia Neonatale del bovino. Nota preliminare 140
Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study 140
EGFR Expression is Predictive of Poor Prognosis in Feline Cutaneous Squamous Cell Carcinoma 139
A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy 138
COMPARISONS AMONG COMPUTED TOMOGRAPHIC FEATURES OF ADIPOSE MASSES IN DOGS AND CATS 137
Clinical relevance of simultaneous histopathological grading of canine cutaneous mast cell tumors at first presentation: a retrospective study on 386 cases. 137
Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy 137
Prognostic Significance of Kit Receptor Tyrosine Kinase Dysregulations in Feline Cutaneous Mast Cell Tumors 136
Grading Cutaneous Mast Cell Tumors in Cats 135
EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival 134
Airway Remodeling in Feline Lungs 133
ASSESSMENT OF EGFR AND HER-2 EXPRESSION AND ERAS-STATUS IN CANINE GASTRIC TUMOURS 132
Histopathological findings and proliferative activity of canine sebaceous gland tumours with a predominant reserve cell population 132
Subcutaneous mast cell tumours: A prospective multi-institutional clinicopathological and prognostic study of 43 dogs 131
Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature 131
A Retrospective Clinico-Pathologic Study of 35 Dogs with Urethral Transitional Cell Carcinoma Undergoing Treatment 130
Immunohistochemical characterization of therapeutic targets in canine bladder cancer 130
Prognosis following surgical excision in canine and feline malignant skin tumors: the role of the histological evaluation of margins. 130
Histologic grade has a higher-weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes 129
Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes 128
Immunohistochemical prognosticators in feline cutaneous and visceral mast cell tumors. 128
Chemo-switch improves outcome in surgically-removed, biologically aggressive canine hemangiosarcoma. 127
Feline large granular lymphocyte lymphoma: an Italian Society of Veterinary Oncology (SIONCOV) retrospective study. 127
Clinical Features and Outcome of 79 Dogs With Digital Squamous Cell Carcinoma Undergoing Treatment: A SIONCOV Observational Study 127
EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model? 126
Linee guida SIONCOV 2023 per diagnosi, stadiazione e trattamento del carcinoma uroteliale di vescica e uretra del cane 125
Combination of radiation therapy and a selective COX-2 inhibitor (firocoxib) in the treatment of canine nasal carcinomas 125
Clinicopathologic features and biologic behavior of canine splenic nodules with stromal, histiocytic and lymphoid components 124
Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours 124
EGFR expression and air pollution carcinogenesis in canine primary lung tumours 123
Role of CT in the Staging of Colorectal Tumors: A Preliminary Study on 10 Dogs 121
Validation of oral brushing as a non-invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis 121
EGFR expression is predictive of a poor prognosis in feline cutaneous squamous cell carcinoma 120
Differentiating feline inflammatory bowel disease from alimentary lymphoma in duodenal endoscopic biopsies 118
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi-institutional retrospective study 116
Immunohistochemical Analysis of Canine Haemangioma and Haemangiosarcoma 115
COMPARISON OF A HYPOFRACTIONATED VERSUS A FULL-COURSE RADIOTHERAPY PROTOCOL FOR THE TREATMENT OF MICROSCOPIC CUTANEOUS MAST CELL TUMOURS IN DOGS. 115
A phase 2, single-arm, open-label clinical trial on adjuvant active immunotherapy in dogs with appendicular osteosarcoma undergoing amputation and chemotherapy 115
CLINICAL OUTCOME OF DOGS WITH UROTHELIAL CARCINOMA TREATED WITH DOSE-INTENSE CHEMOTHERAPY VERSUS RADIO-CHEMOTHERAPY: A SINGLE-INSTITUTIONAL PROSPECTIVE UNBLINDED STUDY. 112
Comparison of sonographic and CT findings for the identification of renal nodules in dogs and cats 111
A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study 111
Histological grading of canine mast cell tumor: is two better than three? 111
Feline intestinal mast cell tumours: clinicopathological characterisation and KIT mutation analysis 108
KIT receptor dyregulations in feline mast cell tumours and systemic mastocytosis 107
The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma 106
Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide 103
Expression Profile of Twelve Transcripts as a Supporting Tool for the Molecular Characterization of Canine Cutaneous Mast Cell Tumors at Diagnosis: Association with Histological Grading and Clinical Staging 102
A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy 102
ESPRESSIONE DI EGFR E CANCEROGENESI DA INQUINAMENTO ATMOSFERICO NEI TUMORI POLMONARI DEL CANE 101
Circulating nucleosomes as a potential cancer biomarker in dogs with splenic nodular lesions 99
KIT receptor tyrosine kinase dysregulation in feline cutaneous mast cell tumour 98
Totale 18.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.483 0 0 0 0 0 197 99 128 217 140 108 594
2021/20222.035 172 94 90 190 243 168 73 139 105 118 351 292
2022/20232.707 248 362 158 282 162 282 110 174 415 119 264 131
2023/20241.840 109 193 111 125 142 221 151 121 76 198 192 201
2024/20254.750 361 582 365 371 639 269 428 230 205 324 301 675
2025/20265.079 728 1.225 883 730 1.089 424 0 0 0 0 0 0
Totale 21.570